Novel Treatment for Glioblastoma
DCA normalises mitochondrial activity in glioblastoma cells, promoting apoptosis
Published: 6th March 2017

Patents
- Granted Patent in US8609724 B2 and Canada CA2604625C
IP Status
- Patented
Seeking
- Licensing
DCA normalises mitochondrial activity in glioblastoma cells, promoting apoptosis